Improving HPV vaccination rates through standing orders

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to enhance HPV vaccination rates among adolescents by implementing standing orders that allow healthcare team members to administer the vaccine without a specific physician's order. It addresses the low vaccination rates in the U.S., particularly among 11-12 year-olds, who are the primary target group for HPV vaccination. The study will also explore how organizational readiness for change influences the effectiveness of these standing orders. By evaluating this approach, the study seeks to provide insights into improving vaccination strategies in healthcare settings.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* active patient in AHP practice

Exclusion Criteria:

* patient belonging to a practice with \>80% UTD baseline HPV vaccination rate for ages 13-17
* patient belonging to a practice with \<20 11-12 year-olds eligible for an HPV dose

Where it's running

• University of Rochester Medical Center (URMC)
  Rochester, New York, United States Recruiting

Study contacts

• Study coordinator: Robin Bender
• Email: robin_bender@urmc.rochester.edu
• Phone: (585) 274-1499

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Can people collect their own vaginal sample for HPV testing as well as clinician collection for comparison?

  This study tests whether individuals can correctly use a self-collection device to gather a vaginal sample for high-risk HPV screening and whether the self-collected sample agrees with clinician-collected samples.

  Recruiting at 11 sites Mel Mont Medical · Phoenix, Arizona and 10 other locations · NCT07758140

• Two-probe thermal ablation for cervical precancer in WLWH in South Africa

  This study tests whether using two probes for thermal ablation is safer or more effective than one probe for treating cervical precancer in women living with HIV in South Africa.

  Recruiting Fred Hutchinson Cancer Center · Durban · NCT07645378

• Two-probe thermal ablation for cervical precancer in WLWH in Zimbabwe

  This study tests whether using two TA probes (endocervical and ectocervical) is better than one probe for treating cervical precancer in women living with HIV in Zimbabwe.

  Recruiting Fred Hutchinson Cancer Center · Harare · NCT07645352

• Digital tools to boost HPV vaccination intentions among Nigerian caregivers

  This study tests whether different online content can help Nigerian parents of unvaccinated girls ages 9-14 decide to vaccinate their daughters against HPV.

  Recruiting University of Pennsylvania · Lagos · NCT07498075

• HPV monitoring after chemoradiotherapy for cervical cancer

  This project will test whether HPV detected on cervical swabs and in blood can find cancer recurrence in people with stage IB–IVA cervical cancer after curative chemoradiotherapy.

  Recruiting General University Hospital, Prague · Prague · NCT07493928

• Two-probe thermal ablation for cervical precancer in HIV+ women in Kenya

  This study tests whether using two probes for thermal ablation is more effective and acceptable than one probe for treating cervical precancer in women living with HIV in Kenya.

  Recruiting Fred Hutchinson Cancer Center · Nairobi · NCT07468695

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.